EE248 Cost Effectiveness of Novel Antiobiotic Imipenem/Cilastatin/Relebactam in Gram Negative Infections in Greece

Autor:	N Yfantopoulos, I Bafaloukos, P Ntontsi, J Yang, E Mintzia, A Skroumpelos, A Karokis
Rok vydání:	2022
Předmět:	Health Policy Public Health Environmental and Occupational Health
Zdroj:	Value in Health. 25:S102
ISSN:	1098-3015
DOI:	10.1016/j.jval.2022.09.496
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::642ca1c8b104e2fbc4205cecbc32c074 https://doi.org/10.1016/j.jval.2022.09.496 Zobrazit plný text záznamu Full Text from ScienceDirect